These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7805989)
1. Cell-mediated immunity in invasive cervical carcinoma associated with human papillomavirus types 16 and 18 infection. Park TK; Kim SN; Lee CH Int J Gynaecol Obstet; 1994 Jul; 46(1):67-8. PubMed ID: 7805989 [No Abstract] [Full Text] [Related]
2. Human papillomavirus types 52 and 58. Lin QQ; Yu SZ; Qu W; Cruz Y; Burk RD Int J Cancer; 1998 Jan; 75(3):484-5. PubMed ID: 9455813 [No Abstract] [Full Text] [Related]
3. HPV testing. Jackson R CAP Today; 2000 Dec; 14(12):11. PubMed ID: 11188344 [No Abstract] [Full Text] [Related]
4. Human papillomavirus in epithelial neoplasia of the vulva and the uterine cervix. On the prevalence and possible significance of some genital HPV infections. Hørding U Dan Med Bull; 1995 Apr; 42(2):155-61. PubMed ID: 7664574 [No Abstract] [Full Text] [Related]
5. Human papillomavirus in carcinogenesis of cervical cancer. de Silva NR; Mendis L; Perera N Ceylon Med J; 1999 Mar; 44(1):45-7. PubMed ID: 10643100 [No Abstract] [Full Text] [Related]
6. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. zur Hausen H J Natl Cancer Inst; 2001 Feb; 93(4):252-3. PubMed ID: 11181763 [No Abstract] [Full Text] [Related]
7. [HPV infection and its significance in cervical oncogenesis]. Zlatkov V Akush Ginekol (Sofiia); 1998; 37(1):45-6. PubMed ID: 9770801 [No Abstract] [Full Text] [Related]
8. [Studies of human papillomavirus infection (HPV) and expression of oncoprotein p 21 in cervix neoplasms]. Markowska J; Harłozińska A; Bar JK; Nowak M; Roszak A; Sedlaczek P Ginekol Pol; 1996 Aug; 67(8):403-6. PubMed ID: 9139009 [TBL] [Abstract][Full Text] [Related]
9. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. Schiffman MH; Castle P J Natl Cancer Inst; 2003 Mar; 95(6):E2. PubMed ID: 12644550 [No Abstract] [Full Text] [Related]
10. Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia. Bekele A; Baay M; Mekonnen Z; Suleman S; Chatterjee S Trop Med Int Health; 2010 Aug; 15(8):890-3. PubMed ID: 20545913 [TBL] [Abstract][Full Text] [Related]
11. [HPV infection and cervical carcinoma--epidemiology, detection and immunology]. Schneider A; Dürst M; Kaufmann AM Zentralbl Gynakol; 2001 Apr; 123(4):179-85. PubMed ID: 11370524 [TBL] [Abstract][Full Text] [Related]
12. [Human papillomavirus and etiology of cervical cancer: concept of carcinogenesis]. Helmerhorst TJ Ned Tijdschr Geneeskd; 2000 Sep; 144(39):1891-2. PubMed ID: 11031685 [No Abstract] [Full Text] [Related]
13. Lymphoepithelioma-like carcinoma of the cervix with prominent eosinophilic infiltrate: an HPV-18 associated case. Saylam K; Anaf V; Fayt I; Noel JC Acta Obstet Gynecol Scand; 2002 Jun; 81(6):564-6. PubMed ID: 12047313 [No Abstract] [Full Text] [Related]
14. Pathobiology of human papillomavirus. Prasad CJ Clin Lab Med; 1995 Sep; 15(3):685-704. PubMed ID: 8542729 [TBL] [Abstract][Full Text] [Related]
15. [Anti-papillomavirus immunologic response and natural history of cervical lesions]. Vinatier D; Dufour P Contracept Fertil Sex; 1997 May; 25(5):339-47. PubMed ID: 9273102 [No Abstract] [Full Text] [Related]
16. [The role of tumor-related papillomavirus infection of the genitals in the genesis of background pathology of the ectocervix, dysplasia and preinvasive cancer of the cervix uteri]. Maksimov SIa; Savicheva AM; Bashmakova MA; Shaimardanova GI; Shipitsina EV; Rybina EV Vopr Onkol; 1999; 45(6):627-9. PubMed ID: 10703510 [No Abstract] [Full Text] [Related]
17. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia. Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160 [TBL] [Abstract][Full Text] [Related]
19. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts. de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and cervical disease in adolescents. Guido R Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]